Physician

Rebecca Stoner Thornhill, M.D.

According to 2025 Medicare claims, Rebecca Thornhill, M.D. (NPI: 1164957916) practices dermatology in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is SKIN CANCER CENTER OF CENTRAL FLORIDA, P.A. (NPI: 1336257450; TIN: 59-3708058) and primary practice location at 34491-8983.

Thornhill's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,334 traditional Medicare patients, billed 8,652 HCPCS/CPT codes, and received $776,797 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 379 prescription claims across 226 beneficiaries totaling $255,872 in drug costs, led by Doxycycline Hyclate (Doxycycline Hyclate). 2018 DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,595 to $255,872. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$388K$777K2021 Medicare payment: $332,561 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $702,143 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $691,841 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $776,797 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20218525,283$332,561
20221,53111,908$702,143
20231,2987,832$691,841
20241,3348,652$776,797

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$189K$379K2017 Drug cost: $3,595 (USD; Tot_Drug_Cst)2018 Drug cost: $9,290 (USD; Tot_Drug_Cst)2019 Drug cost: $46,141 (USD; Tot_Drug_Cst)2021 Drug cost: $29,547 (USD; Tot_Drug_Cst)2022 Drug cost: $189,267 (USD; Tot_Drug_Cst)2023 Drug cost: $378,721 (USD; Tot_Drug_Cst)2024 Drug cost: $255,872 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172638$3,595
201855148$9,290
20191530$46,141
2020N/RN/RN/R
2021145218$29,547
2022331591$189,267
2023295488$378,721
2024226379$255,872

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$657$1.3K2018 Medicare payment: $1,314 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R11$1,314
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths374437$79
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more9201,123$69
11102Biopsy of related skin growth, first growth430520$64
17000Destruction of precancer skin growth, 1 growth706885$38
17003Destruction of precancer skin growth, 2-14 growths5513,079$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Doxycycline HyclateDoxycycline Hyclate97830$844
KetoconazoleKetoconazole19480$628
Gentamicin SulfateGentamicin Sulfate11277$462
Clobetasol PropionateClobetasol Propionate17475$425
Ciprofloxacin HclCiprofloxacin Hcl41323$361

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Rebecca Stoner Thornhill, M.D.?

Tedicare shows public-source Medicare data for Rebecca Stoner Thornhill, M.D. (NPI 1164957916), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rebecca Stoner Thornhill, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rebecca Stoner Thornhill, M.D.?

Rebecca Stoner Thornhill, M.D. is linked to SKIN CANCER CENTER OF CENTRAL FLORIDA, P.A. (billing NPI 1336257450) in the available physician profile data.

Does Rebecca Stoner Thornhill, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.